PAS
NVCR icon

Point72 Asia (Singapore)’s NovoCure NVCR Stock Holding History

Point72 Asia (Singapore)’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$174K Buy
13,431
+2,030
+18% +$27.1K 0.03% 329
2025
Q2 		$203K Buy
11,401
+112
+1% +$1.95K 0.04% 345
2025
Q1 		$201K Buy
11,289
+4,388
+64% +$99.7K 0.05% 277
2024
Q4 		$206K Buy
6,901
+5,008
+265% +$106K 0.05% 239
2024
Q3 		$29.6K Sell
1,893
-91
-5% -$1.65K 0.01% 766
2024
Q2 		$34K Buy
+1,984
New +$34.9K 0.01% 745
2024
Q1 		– Sell
-5,354
Closed -$79.9K – 1179
2023
Q4 		$79.9K Buy
+5,354
New +$71.7K 0.02% 246

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Point72 Asia (Singapore)'s NVCR Position: Q3 2025 in Review

Point72 Asia (Singapore) increased its NovoCure (NVCR) stake by 18% in Q3 2025, buying an estimated $27.1K and bringing the position to 13,431 shares worth $174K. The position accounts for 0.03% of the portfolio, ranked #329.

Point72 Asia (Singapore) first reported a position in NVCR in Q4 2023 and has held it in 7 quarters since. The position peaked at $206K in Q4 2024. 244 funds tracked by Wall St. Rank hold NVCR as of Q3 2025.

  • Point72 Asia (Singapore) held 13,431 shares of NovoCure worth $174K as of Q3 2025.
  • Point72 Asia (Singapore) bought 2,030 NovoCure shares in Q3 2025, an estimated $27.1K.
  • NovoCure made up 0.03% of Point72 Asia (Singapore)'s portfolio in Q3 2025, its #329 holding.
  • Point72 Asia (Singapore) first reported a position in NovoCure in Q4 2023 and has held it in 7 quarters since.
  • Point72 Asia (Singapore)'s NovoCure position peaked at $206K in Q4 2024.
  • 244 funds tracked by Wall St. Rank held NovoCure as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.